Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

METIMYD

PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM

Standard Dose
0.5%;10%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview METIMYD is listed in Drugs@FDA under application 010210 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM Form and strength SUSPENSION/DROPS;OPHTHALMIC - 0.5%;10% Sponsor SCHERING Submission history Latest submission status date: 1999-10-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview METIMYD is listed in Drugs@FDA under application 010210 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM Form and strength SUSPENSION/DROPS;OPHTHALMIC - 0.5%;10% Sponsor SCHERING Submission history Latest submission status date: 1999-10-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.